What they were paid
Prime Medicine Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $60,000 | $0 | $111,611 | $0 | $171,611 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Prime Medicine, Inc. DEF 14A filed April 23, 2026, accession 0001628280-26-026697, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Prime Medicine pays directors a $45,000 cash retainer.
Committees
FY2025 · as the proxy prints themAudit · Nominating/Governance
The rest of the Prime Medicine board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Allan Reine, M.D | Director | $0 |
| David Schenkein, M.D | Independent Director | $196,424 |
| Jeffrey D. Marrazzo | Director | $1,340,110 |
| Kaye Foster | Independent Director | $222,359 |
| Michael Kelly | Independent Director | $227,079 |
| Robert Nelsen | Independent Director | $186,424 |
| Thomas Cahill, M.D., Ph.D | Independent Director | $143,456 |
The full Prime Medicine compensation record
free company briefThis page is one director within Prime Medicine's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat